Trileptal 300 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

trileptal 300 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg

Trileptal 300 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

trileptal 300 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 300 mg

Trileptal 600 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

trileptal 600 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 600 mg

Trileptal 600 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

trileptal 600 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 600 mg

Trileptal 600 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

trileptal 600 mg

orifarm as - okskarbazepin - tablett, filmdrasjert - 600 mg

Dengvaxia यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

dengvaxia

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaksiner - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 og 4. bruk av dengvaxia skal være i samsvar med offisielle anbefalinger.

Trodelvy यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

trodelvy

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastiske midler - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Sugammadex Mylan यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Dimethyl fumarate Mylan यूरोपीय संघ - नॉर्वेजियाई - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Somac 40 mg नॉर्वे - नॉर्वेजियाई - Statens legemiddelverk

somac 40 mg

orifarm as - pantoprazolnatriumsesquihydrat - pulver til injeksjonsvæske, oppløsning - 40 mg